Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications.
Campbell JA, Henson GJ, Ngwa VF, Ahmad H, Taylor BV, van der Mei I; MSBase Australian Researchers; Palmer AJ. Campbell JA, et al. Among authors: henson gj. Pharmacoeconomics. 2024 Aug 2. doi: 10.1007/s40273-024-01417-4. Online ahead of print. Pharmacoeconomics. 2024. PMID: 39095665
Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia.
Campbell JA, Ahmad H, Chen G, van der Mei I, Taylor BV, Claflin S, Henson GJ, Simpson-Yap S, Laslett LL, Hawkes K, Hurst C, Waugh H, Palmer AJ. Campbell JA, et al. Among authors: henson gj. Qual Life Res. 2023 Feb;32(2):553-568. doi: 10.1007/s11136-022-03214-y. Epub 2022 Aug 29. Qual Life Res. 2023. PMID: 36036311 Free PMC article.
Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand.
Claflin S, Campbell JA, Norman R, Mason DF, Kalincik T, Simpson-Yap S, Butzkueven H, Carroll WM, Palmer AJ, Blizzard CL, van der Mei I, Henson GJ, Taylor BV. Claflin S, et al. Among authors: henson gj. Eur J Health Econ. 2023 Aug;24(6):939-950. doi: 10.1007/s10198-022-01518-x. Epub 2022 Sep 23. Eur J Health Econ. 2023. PMID: 36149605 Free PMC article.
Using qualitative free-text data to investigate the lived experience of the COVID-19 pandemic for a large cohort of Australians with different multiple sclerosis related disability levels.
Campbell JA, van der Mei I, Taylor BV, Palmer AJ, Henson GJ, Laslett LL, Simpson-Yap S, Claflin SB. Campbell JA, et al. Among authors: henson gj. J Neurol Neurosurg Psychiatry. 2023 Dec;94(12):975-983. doi: 10.1136/jnnp-2022-330755. Epub 2023 Oct 26. J Neurol Neurosurg Psychiatry. 2023. PMID: 37884346
Investigation of the health economic analysis of informal care for people living with a chronic neurological disease: A systematic review and meta-analysis of the global evidence for multiple sclerosis.
Adal TG, van der Mei I, Taylor BV, de Graaff B, Palmer AJ, Chen G, Henson GJ, Roydhouse J, Campbell JA. Adal TG, et al. Among authors: henson gj. Soc Sci Med. 2024 Dec;363:117405. doi: 10.1016/j.socscimed.2024.117405. Epub 2024 Oct 5. Soc Sci Med. 2024. PMID: 39541831
Correction: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications.
Campbell JA, Henson GJ, Ngwa VF, Ahmad H, Taylor BV, van der Mei I; MSBase Australian Researchers; Palmer AJ. Campbell JA, et al. Among authors: henson gj. Pharmacoeconomics. 2024 Dec 30. doi: 10.1007/s40273-024-01461-0. Online ahead of print. Pharmacoeconomics. 2024. PMID: 39739244 No abstract available.
11 results